Loading...
XJPX
2931
Market cap349mUSD
Dec 05, Last price  
397.00JPY
1D
-1.98%
1Q
-13.32%
Jan 2017
-69.18%
IPO
140.31%
Name

Euglena Co Ltd

Chart & Performance

D1W1MN
XJPX:2931 chart
P/E
P/S
1.22
EPS
Div Yield, %
Shrs. gr., 5y
6.00%
Rev. gr., 5y
26.17%
Revenues
44.39b
+90.59%
1,166,024,0001,585,688,0002,091,978,0003,046,348,0005,924,356,00011,103,230,00013,886,603,00015,174,582,00013,967,671,00013,317,316,00023,291,848,00044,392,000,000
Net income
-2.68b
L-17.01%
204,871,000197,438,000482,540,000118,177,000469,639,000673,344,000785,886,000-1,252,194,000-9,798,460,000-1,486,498,000-3,227,952,000-2,679,000,000
CFO
924m
-38.45%
250,538,00086,174,000163,544,000-7,805,000620,966,000913,588,000153,756,000-1,238,020,0001,089,392,000-1,217,472,0001,501,276,000924,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae. It operates through Healthcare Business and Energy/Environment Business segments. The company also manufactures and sells foods and cosmetics using euglena. In addition, it offers health foods, beverages, confectionery, and sports food products. Further, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. It distributes its products at convenience stores, drugstores, supermarkets, beauty salons, and variety shops. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.
IPO date
Dec 20, 2012
Employees
865
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT